Thomas DiRaimondo

Business address
C/O Janux Therapeutics, Inc., 10955 Vista Sorrento Parkway, Suite 200, San Diego, CA, 92130
Top holdings (ownership)
JANX
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Thomas DiRaimondo has filed 5 SEC EDGAR filings since 03 Jan 2024

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 03 Jan 2025 02 Jan 2025 001-40475
4 Open Document Open Filing 27 Sep 2024 27 Sep 2024 001-40475
144 Open Document Open Filing 27 Sep 2024
4 Open Document Open Filing FORM 4 SUBMISSION 03 Jan 2024 02 Jan 2024 001-40475
3 Open Document Open Filing FORM 3 SUBMISSION 03 Jan 2024 01 Jan 2024 001-40475